Seelos Therapeutics, Inc. Stock Split Ratio
Seelos Therapeutics, Inc. had Stock Split Ratio of 3.00% as of 2023-11-27, per its 10-Q filed 2024-05-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-05-14
- 2023-11-27: Stockholders' Equity Note, Stock Split, Conversion Ratio 3.00%.
- 2016-10-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 10.00%.
- 2016-10-21: Stockholders' Equity Note, Stock Split, Conversion Ratio 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|
| 2023-11-27 | 3.00% 10-Q · filed 2024-05-14 | |
| 2016-10-31 | 10.00% 10-Q · filed 2017-11-02 | |
| 2016-10-21 | 10.00% 10-K · filed 2018-03-01 |